The Zacks Analyst Blog Highlights Home Depot, Johnson & Johnson, Salesforce, Preformed Line and Cooper-Standard
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – December 6, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: The Home Depot, Inc. HD, Johnson & Johnson JNJ, Salesforce, Inc. CRM, Preformed Line Products Co. PLPC and Cooper-Standard Holdings Inc. CPS.Here are highlights from Thursday’s Analyst Blog:Top Analyst Reports for Home Depot, Johnson & Johnson and SalesforceThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc., Johnson & Johnson and Salesforce, Inc., as well as two micro-cap stocks, Preformed Line Products Co. and Cooper-Standard Holdings Inc. These research reports have been hand-picked from roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Home Depot’s shares have underperformed the Zacks Building Products - Retail industry over the past year (+31.2% vs. +37.8%). The Zacks analyst believes that the company’s stock has lagged the industry due to higher interest rates and macroeconomic uncertainty, dampening consumer demand for home improvement. Inflationary pressures, including lumber prices, continue to hurt performance.However, it gains from its “One Home Depot” plan focused on expanding supply chain facilities, technology and improving the digital experience. The interconnected retail strategy and strong technology infrastructure have consistently boosted web traffic in recent quarters.(You can read the full research report on Home Depot here >>>)Johnson & Johnson’s shares have underperformed the Zacks Large Cap Pharmaceuticals industry over the past year (-3.9% vs. +12.5%). The Zacks analyst believes that sales in the MedTech segment have been lower than expected due to Asia-Pacific headwinds, specifically in China. Upcoming patent expiration of the popular drug Stelara can also hurt the drug’s sales. J&J is incurring huge legal expenses due to the pending lawsuits related to its talc products.Yet, its innovative Medicine unit is performing at above-market levels. Growth is being driven by existing products like Darzalex, Tremfya and Erleada and also continued uptake of new launches, including Spravato, Carvykti and Tecvayli.(You can read the full research report on Johnson & Johnson here >>>)Shares of Salesforce have outperformed the Zacks Computer - Software industry over the last six months (+51.5% vs. +10.2%). Per the Zacks analyst, Salesforce is benefiting from a robust demand environment with its sustained focus on aligning products with customer needs driving the top line. Continued deal wins in the international market are another growth driver. Salesforce’s strategy of continuous expansion of generative AI offerings will help it tap the growing opportunitiesHowever, stiff competition and unfavorable currency fluctuations are concerns. Softening IT spending amid ongoing macroeconomic uncertainties might hurt its growth prospects.(You can read the full research report on Salesforce here >>>)Performed Line’s shares have outperformed the Zacks Electronics – Miscellaneous Products industry over the last six months (+5.0% vs. -30.5%). The Zacks analyst believes that a robust market position, diverse product portfolio and solid financial health aid the company. The company’s extensive range of products for energy, telecommunications and other industries, backed by strategic global manufacturing facilities, ensures a competitive edge.Yet, it faces near-term risks, including declining sales driven by weakness in the communications market, margin compression, foreign exchange challenges, slowdown in customer deployments and delays in stimulus funding.(You can read the full research report on Performed Line here >>>)Cooper-Standard’s shares have outperformed the Zacks Automotive – Original Equipment industry over the last six months (+10.8% vs. -6.1%). The Zacks analyst believes that strategic cost optimization, strong market position in sealing and fluid handling systems and key ties to Ford and GM, bolsters revenue stability and positions it well in the growing hybrid/EV market.Yet, significant liquidity challenges, ongoing losses, high debt levels and exposure to global light vehicle production fluctuations are concerning. Also, inflationary pressures and pension obligations present substantial risks.(You can read the full research report on Cooper-Standard here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Salesforce Inc. (CRM): Free Stock Analysis Report Johnson & Johnson (JNJ): Free Stock Analysis Report The Home Depot, Inc. (HD): Free Stock Analysis Report Cooper-Standard Holdings Inc. (CPS): Free Stock Analysis Report Preformed Line Products Company (PLPC): Get Free ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Cooper
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cooper
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Salesforce
Analysen zu Salesforce
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2024 | Salesforce Buy | Jefferies & Company Inc. | |
04.12.2024 | Salesforce Overweight | JP Morgan Chase & Co. | |
04.12.2024 | Salesforce Neutral | UBS AG | |
04.12.2024 | Salesforce Buy | Goldman Sachs Group Inc. | |
22.11.2024 | Salesforce Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2024 | Salesforce Buy | Jefferies & Company Inc. | |
04.12.2024 | Salesforce Overweight | JP Morgan Chase & Co. | |
04.12.2024 | Salesforce Buy | Goldman Sachs Group Inc. | |
20.11.2024 | Salesforce Overweight | JP Morgan Chase & Co. | |
11.11.2024 | Salesforce Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2024 | Salesforce Neutral | UBS AG | |
22.11.2024 | Salesforce Neutral | UBS AG | |
19.09.2024 | Salesforce Neutral | UBS AG | |
29.08.2024 | Salesforce Neutral | UBS AG | |
30.05.2024 | Salesforce Neutral | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
11.01.2023 | Salesforce Underperform | Bernstein Research | |
19.06.2020 | Slack Sell | Goldman Sachs Group Inc. | |
19.05.2016 | Salesforce Underperform | Bernstein Research | |
19.11.2015 | Salesforce Underperform | Bernstein Research | |
19.11.2015 | Salesforce verkaufen | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Salesforce nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen